Biotest AG - Company Profile
Powered by
All the data and insights you need on Biotest AG in one report.
- Save hours of research time and resources with
our up-to-date Biotest AG Strategy Report
- Understand Biotest AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Biotest AG (Biotest) supplies plasma protein products and biotherapeutic drugs. The company’s presence in the healthcare value chain, focus on R&D and distribution partnerships are its strengths even as history of operating losses could be a cause for concern to the company. Biotest could benefit from strategic agreements, market potential of Hemophilia A and B, and robust product pipeline. However, changing technologies and intense competition, government regulations and uncertain R&D outcomes could affect its financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer